热景生物
(688068)
| 流通市值：60.06亿 | | | 总市值：60.06亿 |
| 流通股本：9275.41万 | | | 总股本：9275.41万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 192,280,174.78 | 216,376,723.1 | 111,784,144.17 | 536,839,864.72 |
| 交易性金融资产 | 875,194,290.09 | 983,948,002.8 | 1,101,406,710.31 | 830,334,049.28 |
| 应收票据及应收账款 | 120,141,158.34 | 116,036,159.14 | 144,602,467.48 | 118,172,051.45 |
| 其中：应收票据 | 316,400 | 274,748.6 | 10,459,602.89 | 141,400 |
| 应收账款 | 119,824,758.34 | 115,761,410.54 | 134,142,864.59 | 118,030,651.45 |
| 应收款项融资 | - | 331,009 | - | 310,752 |
| 预付款项 | 33,191,865.61 | 33,741,488.85 | 55,669,902.65 | 23,466,360.06 |
| 其他应收款合计 | 4,660,724.3 | 5,485,846.6 | 3,858,508.53 | 1,355,340.44 |
| 存货 | 87,471,308.31 | 88,411,568.27 | 59,596,272.21 | 79,356,432.64 |
| 其他流动资产 | 13,952,916.54 | 11,348,993.14 | 9,310,422.34 | 7,152,190.3 |
| 流动资产合计 | 1,326,892,437.97 | 1,455,679,790.9 | 1,486,228,427.69 | 1,596,987,040.89 |
| 非流动资产: | | | | |
| 长期股权投资 | 343,101,773.42 | 319,472,942.46 | 351,622,188.89 | 334,313,897.95 |
| 其他权益工具投资 | 192,963,646.69 | 192,963,646.69 | 167,917,453.05 | 143,523,643.1 |
| 投资性房地产 | 80,206,296.31 | 80,931,123.64 | 95,383,829.69 | 72,421,291.28 |
| 固定资产 | 881,672,838.14 | 874,944,406.41 | 865,194,450.91 | 901,547,643.2 |
| 在建工程 | 1,488,604.25 | 856,687.78 | 1,190,346.07 | 121,061.95 |
| 使用权资产 | 44,347.32 | 153,647.94 | 3,224,089.99 | 524,889.25 |
| 无形资产 | 45,834,590.57 | 46,725,593.89 | 47,807,591.04 | 48,520,662.07 |
| 开发支出 | 2,606,328.57 | 1,081,460.69 | 676,924.79 | 674,094.6 |
| 长期待摊费用 | 15,420,439.4 | 16,458,243.68 | 16,986,497.64 | 19,478,408.93 |
| 递延所得税资产 | 36,922,502.84 | 36,290,553.36 | 18,452,332.22 | 35,414,889.01 |
| 其他非流动资产 | 19,666,002.83 | 38,062,318.01 | 36,404,744.77 | 26,352,669.23 |
| 非流动资产平衡项目 | 0 | 0 | -0.01 | 0 |
| 非流动资产合计 | 1,619,927,370.34 | 1,607,940,624.55 | 1,604,860,449.05 | 1,582,893,150.57 |
| 资产总计 | 2,946,819,808.31 | 3,063,620,415.45 | 3,091,088,876.74 | 3,179,880,191.46 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 50,018,750 |
| 应付票据及应付账款 | 90,782,271.36 | 100,475,073.4 | 132,060,370.5 | 105,206,744.07 |
| 其中：应付票据 | 28,529,600.9 | 25,009,527.84 | 16,424,043.8 | - |
| 应付账款 | 62,252,670.46 | 75,465,545.56 | 115,636,326.7 | 105,206,744.07 |
| 预收款项 | - | - | 2,865,499.88 | - |
| 合同负债 | 15,269,222.43 | 17,816,211.81 | 14,958,664.98 | 13,136,564.19 |
| 应付职工薪酬 | 22,270,161.44 | 23,830,358.39 | 22,105,291.51 | 29,922,970.11 |
| 应交税费 | 2,797,775.02 | 2,973,506.79 | 5,330,772.09 | 4,751,615.68 |
| 其他应付款合计 | 32,675,545.12 | 32,422,470.23 | 39,806,103 | 43,275,163.48 |
| 一年内到期的非流动负债 | 5,826.74 | 23,811.26 | 42,308.08 | 336,590.38 |
| 其他流动负债 | 2,088,980.44 | 1,527,861.49 | 3,424,952.98 | 1,384,244.66 |
| 流动负债合计 | 165,889,782.55 | 179,069,293.37 | 220,593,963.02 | 248,032,642.57 |
| 非流动负债: | | | | |
| 租赁负债 | 41,799.17 | 74,644.5 | 3,795,030.5 | 130,439.37 |
| 递延收益 | 22,187,646.23 | 22,187,646.23 | 11,098,089.91 | 11,068,089.91 |
| 递延所得税负债 | - | - | - | 9,913.21 |
| 其他非流动负债 | 275,579,780.82 | 271,693,095.88 | 263,998,046.5 | 264,046,465.75 |
| 非流动负债合计 | 297,809,226.22 | 293,955,386.61 | 278,891,166.91 | 275,254,908.24 |
| 负债合计 | 463,699,008.77 | 473,024,679.98 | 499,485,129.93 | 523,287,550.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 92,754,116 | 92,754,116 | 92,707,940 | 92,707,940 |
| 资本公积 | 242,429,835.68 | 240,843,791.35 | 171,086,667.29 | 163,819,351.1 |
| 减:库存股 | 363,855,082.52 | 363,855,082.52 | 338,106,253.66 | 338,548,439.72 |
| 其他综合收益 | 53,400,286.67 | 53,148,861.25 | 29,465,782.52 | 23,363,738.53 |
| 盈余公积 | 48,556,074.11 | 48,556,074.11 | 48,556,074.11 | 48,556,074.11 |
| 未分配利润 | 2,287,540,793.03 | 2,370,244,651.79 | 2,428,312,737.92 | 2,496,372,118.97 |
| 归属于母公司股东权益合计 | 2,360,826,022.97 | 2,441,692,411.98 | 2,432,022,948.18 | 2,486,270,782.99 |
| 少数股东权益 | 122,294,776.57 | 148,903,323.49 | 159,580,798.63 | 170,321,857.66 |
| 股东权益合计 | 2,483,120,799.54 | 2,590,595,735.47 | 2,591,603,746.81 | 2,656,592,640.65 |
| 负债和股东权益合计 | 2,946,819,808.31 | 3,063,620,415.45 | 3,091,088,876.74 | 3,179,880,191.46 |
| 公告日期 | 2026-10-31 | 2026-08-27 | 2026-04-25 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |